USA - NYSE:SNV - US87161C5013 - Common Stock
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.36B | 1.99B | 2.21B | 2.21B | 1.98B | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 1.84B | 1.75B | 1.82B | 1.80B | 1.53B | |||
| Non Interest Income | 516.88M | 239.60M | 390.88M | 409.34M | 450.10M | |||
| Loan Loss Provision | 68.72M | 136.69M | 175.95M | 84.55M | -106.30M | |||
| Net Interest Income after Provision | 1.77B | 1.61B | 1.64B | 1.71B | 1.64B | |||
| Non Interest Expense | -1.28B | -1.25B | -1.34B | -1.16B | -1.10B | |||
| Minority Interest Expense | 2.28M | 3.01M | 1.56M | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 1.01B | 604.95M | 696.16M | 964.18M | 989.40M | |||
| Income Tax | 212.15M | 125.50M | 154.02M | 206.28M | 228.90M | |||
| Net Income | 754.45M | 439.56M | 507.75M | 724.74M | 727.30M | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 5.3561 | 3.0315 | 3.4604 | 4.9477 | 4.9 | |||
| Non GAAP EPS | 5.49 | 4.5 | 4.39 | 4.94 | 4.96 | |||
| Statistics | ||||||||
| Profit Margin | 31.96% | 22.10% | 23.00% | 32.85% | 36.68% | |||
All data in USD